Cargando…
22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome
BACKGROUND: Given the limited collaborative international studies that evaluated COVID-19 in patients with cancer in comparison to patients without cancer, we aimed to determine the independent risk factors associated with increased 30-day mortality and the impact of novel treatment modalities in a...
Autores principales: | Hachem, Ray Y, Chaftari, Anne-Marie, Masayuki, Nigo, Hamerschlak, Nelson, Dagher, Hiba, Jiang, Ying, Siddiqui, Bilal, Bayle, Arnaud, Somer, Robert, Cruz, Ana Fernandez, Gorak, Edward, Bhinder, Arvinder, Mori, Nobuyoshi, Datoguia, Tarcila, Shelanski, Samuel, Dragvich, Tomislav, Kiat, Yee Elise Vong, Fakhreddine, Suha, Hanna, Pierre Abi, Chemaly, Roy F, Mulanovich, Victor E, Adachi, Javier, Borjan, Jovan, Khawaja, Fareed, Granwehr, Bruno, John, Teny, Guevara, Eduardo Yepez, Torres, Harrys A, Slavin, Monica, Teh, Benjamin, Subbiah, Vivek, Kontoyiannis, Dimitrios P, Malek, Alexandre, Raad, Issam I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644395/ http://dx.doi.org/10.1093/ofid/ofab466.022 |
Ejemplares similares
-
293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
por: Chaftari, Anne-Marie, et al.
Publicado: (2021) -
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
por: Raad, Issam I, et al.
Publicado: (2023) -
372. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study
por: Hachem, Ray Y, et al.
Publicado: (2020) -
1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy
por: Malek, Alexandre, et al.
Publicado: (2021) -
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
por: Amarante-Mendes, Gustavo P., et al.
Publicado: (2022)